Blocked from discussing new research, Dr Kevin Hall said he doubted if he could continue to freely conduct ‘unbiased science’ ...

Pearsanta has secured approval from WCG Clinical’s IRB to begin a clinical trial of the blood-based Mitomic Endometriosis ...

GeneDx has announced its intention to acquire Fabric Genomics, a move that positions it to advance in the field of genomic ...

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...

Health Canada has granted approval for NanoSpeed Diagnostics’ Test4D Serum, designed to identify Vitamin D levels in blood ...

The US Food and Drug Administration (FDA) has granted marketing authorisation for ActiveProtective Technologies’ (APT) Tango ...

Cadwell Industries has made a strategic investment in the Australian company Seer Medical, which specialises in epilepsy ...

Genesis has gained US Food and Drug Administration (FDA) clearance on an Investigational New Drug (IND) application for a ...

The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

The University of Birmingham has secured £230,00 ($303,000) in funding from Cancer Research Horizons towards the development ...

Edwards’ device, dubbed Sapien M3, is the first approved system to use a transfemoral approach to treating mitral ...

Researchers from Weill Cornell Medicine (WCM) and New York Genome Center (NYGC), US, have identified an “accurate” and ...